Lee Chan Henry sold $157K of ONC
Lee Chan Henry (SVP, General Counsel) sold 590 shares of BeOne Medicines Ltd. (ONC) at $265.98 ($0.16M total) on 2026-06-16.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market sale amount, date, and post-transaction holdings (0 shares).
Market read
Traders may monitor for follow-on insider activity, but the filing alone does not change fundamentals or provide new operational/financial guidance.
What to watch
No 10b5-1 plan is stated, but the article also provides no context on prior grants, vesting schedules, or whether other insiders/funds are trading—so signal-to-noise is low.
Background
This is an SEC Form 4 insider transaction disclosure for BeOne Medicines Ltd. (ONC).
Ticker impact
SEC Form 4 shows ONC’s SVP & General Counsel Lee Chan Henry sold 590 shares on 2026-06-16 for $156,925.25.
Likely limited near-term impact; any reaction should be small and short-lived unless followed by additional insider activity or company-specific news.
The filing is primary-source and specific, but the transaction is a relatively small, single insider sale with no accompanying company event or guidance change in the text.
Market effects
Minimal; this is company-specific insider trading with no sector-wide regulatory/clinical/financing signal in the text.
None indicated.
None indicated.
Counterpoint
The sale could be purely liquidity/tax-driven and not predictive, especially since the filing does not cite any adverse company development.
Key entities
- issuerBeOne Medicines Ltd.
Subject of the Form 4 insider transaction disclosure (ONC).
- insiderLee Chan Henry
SVP, General Counsel; sold 590 shares on 2026-06-16.
